Related Experiment Videos
Atrial fibrillation after intravenous dipyridamole for thallium imaging
1Institute of Nuclear Medicine, University College and Middlesex School of Medicine, London, UK.
Insights
Dipyridamole administration for thallium tomography after myocardial infarction rarely caused fast atrial fibrillation. This cardiac arrhythmia resolved spontaneously within three days, suggesting a direct electrophysiological effect.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Myocardial infarction (MI) necessitates diagnostic imaging, often utilizing thallium tomography.
- Dipyridamole is a common pharmacologic stress agent for thallium tomography.
- Adverse cardiac events during pharmacologic stress testing require careful monitoring and management.
Observation:
- A patient undergoing intravenous dipyridamole administration for thallium tomography post-MI developed rapid atrial fibrillation.
- The induced atrial fibrillation was refractory to aminophylline treatment.
- Spontaneous conversion to sinus rhythm occurred within three days.
Findings:
- Myocardial tomography confirmed apical infarction with no evidence of reversible ischemia.
- The case highlights a rare adverse effect of dipyridamole, specifically atrial fibrillation.
- The arrhythmia's resolution pattern suggests a direct electrophysiological impact on atrial tissue.
Implications:
- Clinicians should be aware of the potential for dipyridamole-induced atrial fibrillation, although rare.
- This observation may contribute to understanding the electrophysiological mechanisms of dipyridamole.
- Further investigation into dipyridamole's cardiac electrophysiologic effects is warranted.
Abstract:
Dipyridamole 0.56 mg/kg was administered intravenously for thallium tomography after myocardial infarction. Fast atrial fibrillation developed which failed to resolve with aminophylline. Sinus rhythm returned within 3 days. Myocardial tomography revealed apical infarction without reversible ischaemia. Atrial fibrillation after dipyridamole is rare and may be caused by direct electrophysiological effects on the atrial myocardium.